Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Ireland - Press Releases
- 7139 Press Releases ·
- RSS
Published on Mon 28 Apr 2025 7:32:56 UTC
TodayJakes unveils historic leadership shift, entrusting a legacy years in the making as he ushers in a new era and expands his global mission
Published on Mon 28 Apr 2025 7:32:53 UTC
ABBOTT PARK, Ill., April 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) has announced new data from its VoltCE Mark Study that show strong safety and efficacy out to 12 months for patients receiving pulsed field ablation (PFA) therapy with the Volt PFA System for the treatment of atrial fibrillation (AFib). The data also highlights the excellent safety profile of the Volt PFA System alongside the system's ability to achieve results with fewer therapy applications (just 4.7 applications per vein on average) than on-market competitive PFA systems.
Published on Mon 28 Apr 2025 7:32:49 UTC
GALWAY, Ireland and SAN DIEGO, April 26, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation (AFib) patients treated with the Affera family of technologies, including the next-generation Sphere-360 single-shot pulsed field ablation (PFA) catheter and the groundbreaking Sphere-9 combination mapping and dual-energy focal PFA catheter. Data were presented in High Impact Science Sessions at the Heart Rhythm Society 2025 Annual Meeting in San Diego; the Sphere-360 study was simultaneously published in the Heart Rhythm Journal.
Published on Mon 28 Apr 2025 7:32:47 UTC
PISCATAWAY, N.J., April 26, 2025 /PRNewswire/ --Bestzyme is pleased to announce a flagship product Mellia Brazzein, has officially received the "No Questions" letter from the U.S. Food and Drug Administration (FDA) regarding its GRAS (Generally Recognized as Safe) status. The GRAS designation recognizes it as general-purpose sweetener for a wide range of applications in the food and beverage industry.
Published on Mon 28 Apr 2025 7:32:45 UTC
CHENGDU, Chine, 27 avril 2025 /PRNewswire/ -- Keymed BiosciencesInc. (HKEX: 02162) (Keymed ou la socit) a rcemment annonc que le CM518D1, un conjugu anticorps-mdicament (ADC) ciblant la CDH17 et mis au point par Keymed, a t autoris comme nouveau mdicament de recherche par le Centre d'valuation des mdicaments de l'Administration nationale des produits mdicaux et fait actuellement l'objet d'essais cliniques de phasesI/II en Chine pour le traitement de tumeurs solides. Cette tape marque une nouvelle avance dans le dveloppement des mdicamentsADC de Keymed, qui renforce ainsi son pipeline thrapeutique innovant dans le domaine de l'oncologie.
Published on Mon 28 Apr 2025 7:32:43 UTC
CHENGDU, China, 27. April 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) (Keymed" oder das Unternehmen") gab vor kurzem bekannt, dass CM518D1, ein von Keymed entwickeltes Antikrper-Wirkstoff-Konjugat (ADC), das auf CDH17 abzielt, vom Center for Drug Evaluation (CDE) der National Medical Products Administration (NMPA) die Zulassung fr ein neues Prfprparat (IND) erhalten hat und derzeit in China in klinischen Studien der Phase I/II zur Behandlung von soliden Tumoren getestet wird. Dieser Meilenstein markiert einen weiteren Durchbruch in Keymeds ADC Medikamentenentwicklung und strkt die innovative therapeutische Pipeline in der Onkologie.
Published on Mon 28 Apr 2025 7:32:42 UTC
CHENGDU, China, 27 de abril de 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" o la "compaa") anunci recientemente que CM518D1, un conjugado anticuerpo-frmaco (ADC) dirigido a CDH17 desarrollado por Keymed, recibi la aprobacin como Nuevo Medicamento en Investigacin (IND) del Centro de Evaluacin de Medicamentos (CDE) de la Administracin Nacional de Productos Mdicos (NMPA), y actualmente se encuentra en ensayos clnicos de Fase I/II en China para el tratamiento de tumores slidos. Este hito marca un nuevo avance en el desarrollo de frmacos ADC de Keymed, fortaleciendo an ms su innovadora cartera de productos teraputicos en oncologa.
Published on Mon 28 Apr 2025 7:32:40 UTC
SAN DIEGO, April 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from theAVEIR Conduction System Pacing (CSP) acute clinical feasibility study, which demonstrated the safety and performance of the investigational AVEIR CSP leadless pacemaker technology. The AVEIR CSP acute clinical feasibility study is the world's first assessment of a leadless pacemaker delivering conduction pacing to the heart's left bundle branch (LBB) area.CSP is a novel pacing approach that targets the LBB area by enabling pacing that mimics the heart's natural electrical rhythm.
Published on Mon 28 Apr 2025 7:32:36 UTC
More than 3,100 athletes swim, bike and run through downtown St. Petersburg as Dubrick wins second year in a row
Published on Mon 28 Apr 2025 7:32:23 UTC
CAMBRIDGE, Mass., April 27, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integratedsolutionsfrom "Idea to IND" (I to ITM), today announcedthat its partner, Pfizer, has presented preclinical data onPF-08052666 (HBM9033; SGN-MesoC2), afirst-in-class topoisomerase 1 inhibitor (TOP1i)-based antibody-drug conjugate (ADC) targeting mesothelin (MSLN), at the AACR Annual Meeting 2025. This ADC was originally developed using Nona Biosciences' proprietary Harbour Miceand integrated ADC platforms. Pfizer acquired its global clinical development and commercialization rights on December 14, 2023.
Published on Mon 28 Apr 2025 7:32:21 UTC
SAN FRANCISCO and SUZHOU, China, April 27, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies, tri-specific antibodies as well as bispecific antibody-drug-conjugates (ADCs) from its oncology pipeline will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025. The AACR meeting will take place April 25-30, 2025, in Chicago, Illinois.
Published on Mon 28 Apr 2025 7:32:19 UTC
SUZHOU, China, April 27, 2025 /PRNewswire/ -- From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster presentation at American Association for Cancer Research ("AACR") annual meeting.
Published on Mon 28 Apr 2025 7:32:16 UTC
SHANGHAI, April 27, 2025 /PRNewswire/ --Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics02256.HK) today announced that it has presented four late-breaking pre-clinical research posters at the 2025 AACR conference held in Chicago, Illinois (USA) from April 25 to April 30. Results were shared for ABSK112 (EGFR exon20ins inhibitor), ABSK131 (PRMT5*MTA inhibitor), and ABK-KRAS-1 (pan-KRAS inhibitor), as well as results from a study investigating potential resistance mechanisms to KRAS G12C inhibitors.
Published on Mon 28 Apr 2025 7:32:14 UTC
- OMRON Healthcare dona 4.000 monitores de presin arterial y avanza en la deteccin de fibrilacin auricular con tecnologa Intellisense AFib basada en IA
Published on Mon 28 Apr 2025 7:32:12 UTC
-Intellisense AFib-Technologie erkennt bei jeder Messung mgliches Vorhofflimmern; der 17. Mai ist Welt-Blutdrucktag im, dem Monat der Blutdruckmessung -May Measurement Month -
Published on Mon 28 Apr 2025 7:32:09 UTC
OSLO, Norway, April 28, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, today announced the 18-month follow-up results from its Phase 1 clinical trial (RAD-18-001) evaluating Radspherin in patients with platinum-sensitive recurrent ovarian cancer and peritoneal carcinomatosis. The trial was closed for recruitment at the end of 2023 and patients are currently in long-term follow-up.
Published on Mon 28 Apr 2025 7:32:07 UTC
OSLO, Norway, April 28, 2025 /PRNewswire/ -- In connection with the release of the first quarter 2025 company update,Oncoinvent invites for a Live streamed of quarterly presentation in English on Wednesday 30thof April at 11.00 AM CEST. A webcast will be available for everyone to view on www.oncoinvent.com. There will be a possibility for Q&A through the MS Teams Webinar.
Published on Mon 28 Apr 2025 7:32:01 UTC
NEW ORLEANS, April 25, 2025 /PRNewswire/ -- Hydro-Tail proudly announces the launch of the first and only innovative universal water attachment designed for all power tools, effectively suppressing silica dust at the point of contact when cutting Tile, stone, brick, block, pavers, etc. This groundbreaking product, developed through unwavering perseverance and ingenuity, is now patent pending and ready to revolutionize the construction industries.
Published on Mon 28 Apr 2025 7:31:58 UTC
MAUMEE, Ohio, April 24, 2025 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) announced today that its board of directors has declared a dividend on its common stock.
Published on Mon 28 Apr 2025 7:31:52 UTC
Statement of Carrie Arblaster, Director, Midwest Advocacy Programs, Campaign for Tobacco-Free kids
Published on Mon 28 Apr 2025 7:31:46 UTC
Equity Insider News Commentary
Published on Mon 28 Apr 2025 7:28:48 UTC
NEWCASTLE, England, April 25, 2025 /PRNewswire/ -- Sam Gills, Design Engineer at Star Refrigeration, has been honoured with the Chartered Institution of Building Services Engineers (CIBSE) Student of the Year North East award, recognising his outstanding academic achievements in Building Services Engineering at Teesside University.
Published on Mon 28 Apr 2025 7:28:41 UTC
BANGALORE, India, April 25, 2025 /PRNewswire/ -- Photo Detector Market is Segmented by Type (Portable Type, Stationary Type), by Application (Consumer Electronics, Industrial Equipment, Aerospace And Defense, Automobile).
Published on Mon 28 Apr 2025 7:28:37 UTC
CLEVELAND, April 25, 2025 /PRNewswire/ -- Ohio middle school students will step into the shoes of real-world NASA professionals for a day of career exploration and hands-on activities at NASA's Glenn Research Center in Cleveland. Nearly 200 students are slated to participate in TECH Day at NASA Glenn on May 1, from 10 a.m. to 1 p.m. Media are invited to attend.
Published on Mon 28 Apr 2025 7:28:21 UTC
WESTERVILLE, Ohio, April 25, 2025 /PRNewswire/ -- Ohio Laborers-Employers Cooperation and Education Trust (LECET) spent the week highlighting the critical importance of work zone safety and showing appreciation for highway construction workers during National Work Zone Awareness Week (April 21-25, 2025). The organization demonstrated its commitment to worker safety and community well-being through a series of impactful initiatives.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities